Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Spectral Medical (EDT) Stock Price & Analysis

EDT Stock Chart & Stats

CA$1.03CA$0.00(0.00%)
At close: 11:28 AM EST
C$1C$1.2C$1.410 Aug24 Aug8 Sep21 Sep5 Oct19 Oct2 Nov
Day’s Range
CAD 1.00 - CAD 1.06
52-Week Range
CAD 0.86 - CAD 1.54
Previous Close
CAD 1.03
Volume
N/A
Average Volume (3M)
50.37K
Market Cap
CAD 303.48M
Enterprise Value
CAD 411.25M
Total Cash (Recent Filing)
CAD 803.00K
Total Debt (Recent Filing)
CAD 25.68M
Price to Earnings (P/E)
―
Beta
0.92
Next Earnings
Nov 06, 2026 (Est.)
EPS Estimate
-0.01
Last Dividend Ex-Date
Dec 19, 2011
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Critical-care Focus

A concentrated focus on critical-care therapies and diagnostics gives Spectral a clear strategic identity and targets a serious clinical need. Continued development around septic shock can support focused clinical expertise, product refinement, and a coherent commercialization strategy over the medium term.

Integrated Therapy And Diagnostic Platform

Combining a targeted endotoxin-removal therapy with a test intended to identify suitable patients creates a coordinated product approach. If clinically validated, this pairing could improve treatment selection and make the company’s offering more differentiated than an isolated device or diagnostic.

Loss Reduction

A narrower net loss provides a modest sign that reported performance has moved in a better direction than the prior year. If this improvement persists alongside revenue development and cost discipline, it could gradually reduce the distance to break-even, though profitability remains unproven.

Bears Say

Small And Declining Revenue Base

Very low and recently declining revenue limits operating scale and leaves the business with little commercial cushion. The inconsistent top-line trend makes it harder to demonstrate durable product adoption, support fixed costs, or fund clinical and commercialization activities from internally generated sales.

Severe Unprofitability

Deep gross losses and an exceptionally negative net margin show that the current business model is not economically viable at its present scale. Sustained losses can consume capital, restrict investment choices, and make future earnings dependent on substantial operating improvement rather than normal revenue growth.

Stressed Balance Sheet And Cash Burn

Negative equity, rising debt, and persistent operating cash burn leave Spectral with limited financial flexibility. Continued funding needs may constrain product development and increase reliance on external financing, while the thin asset base provides little cushion against further operating losses.

Spectral Medical News

EDT FAQ

What was Spectral Medical’s price range in the past 12 months?
Spectral Medical lowest stock price was C$0.86 and its highest was C$1.54 in the past 12 months.
What is Spectral Medical’s market cap?
Spectral Medical’s market cap is C$303.48M.
When is Spectral Medical’s upcoming earnings report date?
Spectral Medical’s next earnings report is estimated for Nov 06, 2026 (not yet confirmed), which is in 3 days.
How were Spectral Medical’s earnings last quarter?
Spectral Medical released its earnings results on Aug 07, 2026. The company reported C$0 earnings per share for the quarter, beating the consensus estimate of -C$0.01 by C$0.01.
Is Spectral Medical overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Spectral Medical pay dividends?
Spectral Medical pays a Notavailable dividend of C$0.12 which represents an annual dividend yield of ―. See more information on Spectral Medical dividends here
What is Spectral Medical’s EPS estimate?
Spectral Medical’s EPS estimate is -0.01.
How many shares outstanding does Spectral Medical have?
Spectral Medical has 294,640,630 shares outstanding.
What happened to Spectral Medical’s price movement after its last earnings report?
Spectral Medical reported an EPS of C$0 in its last earnings report, beating expectations of -C$0.01. Following the earnings report the stock price went up 0.714%.
Which hedge fund is a major shareholder of Spectral Medical?
Currently, no hedge funds are holding shares in TSE:EDT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology